Mary Huber
Child & Adolescent Psychiatry · Atlanta, GANPI 1619007192
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 363 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 363 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$755
- Tris Pharma Inc$668
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$663
- AbbVie$569
- Otsuka America Pharmaceutical, Inc.$448
- Lundbeck LLC$418
- plus $3K from 23 others
What the payments were for
- Food & beverage$6,808100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 33 | $755 |
| Tris Pharma Inc | 39 | $668 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $663 |
| AbbVie(2 entities) | 36 | $569 |
| Otsuka America Pharmaceutical, Inc. | 25 | $448 |
| Lundbeck LLC | 22 | $418 |
| Johnson & Johnson | 23 | $416 |
| Corium, LLC | 19 | $347 |
| Sunovion Pharmaceuticals Inc. | 21 | $329 |
| Ironshore Pharmaceuticals Inc. | 16 | $326 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $286 |
| Neurocrine Biosciences, Inc. | 17 | $254 |
| Axsome Therapeutics, Inc. | 9 | $233 |
| Bausch Health US, LLC | 10 | $195 |
| Neos Therapeutics, LP | 7 | $115 |
| Collegium Pharmaceutical, Inc. | 6 | $108 |
| Teva Pharmaceuticals USA, Inc. | 6 | $107 |
| Merck | 6 | $101 |
| Idorsia Pharmaceuticals US Inc | 5 | $92 |
| Noven Therapeutics, LLC | 3 | $66 |
| Adlon Therapeutics L.p. | 4 | $63 |
| Shire North American Group Inc | 3 | $63 |
| Alfasigma USA, Inc. | 4 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Alkermes, Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$6,808 in reported general payments places this provider in the 90th percentile of 91 child & adolescent psychiatry providers in Georgia.
See all child & adolescent psychiatry providers in Georgia →
Other child & adolescent psychiatry in Atlanta
- Suneel KatragaddaAtlanta$460K
- Olujimi AdefisanAtlanta$14K
- Mhd AlkhatibAtlanta$7K
- Douglas ChanAtlanta$4K
- Jane LanierAtlanta$3K
- Satyanarayana GedelaAtlanta$3K
- Ericka GoodwinAtlanta$1K
- Kerry SheahanAtlanta$1K
- Debora JohnsonAtlanta$695
- Melanie PointerAtlanta$669
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.